Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.477 USD | -2.05% | -15.43% | -87.00% |
08/04 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
21/03 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
Chart: Technical Analysis
- Stock Market
- Equities
- KA Stock
- Charts Kineta, Inc.